Cargando…

The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation

Atrial fibrillation is a major cardiac cause of stroke, and a pathogenesis involving thrombus formation in patients with atrial fibrillation is well established. A strategy for rhythm control that involves catheter ablation and anticoagulation therapy is evolving. A strategy for rhythm control that...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Hoon, Roh, Seung-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901955/
https://www.ncbi.nlm.nih.gov/pubmed/27283277
http://dx.doi.org/10.5853/jos.2016.00234
_version_ 1782436905926787072
author Kim, Young-Hoon
Roh, Seung-Young
author_facet Kim, Young-Hoon
Roh, Seung-Young
author_sort Kim, Young-Hoon
collection PubMed
description Atrial fibrillation is a major cardiac cause of stroke, and a pathogenesis involving thrombus formation in patients with atrial fibrillation is well established. A strategy for rhythm control that involves catheter ablation and anticoagulation therapy is evolving. A strategy for rhythm control that restores and maintains sinus rhythm should reduce the risk of ischemic stroke that is associated with atrial fibrillation; however, this is yet to be proven in large-scale randomized controlled trials. This paper reviews the emerging role of rhythm control therapy for atrial fibrillation to prevent stroke.
format Online
Article
Text
id pubmed-4901955
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Stroke Society
record_format MEDLINE/PubMed
spelling pubmed-49019552016-06-14 The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation Kim, Young-Hoon Roh, Seung-Young J Stroke Special Review Atrial fibrillation is a major cardiac cause of stroke, and a pathogenesis involving thrombus formation in patients with atrial fibrillation is well established. A strategy for rhythm control that involves catheter ablation and anticoagulation therapy is evolving. A strategy for rhythm control that restores and maintains sinus rhythm should reduce the risk of ischemic stroke that is associated with atrial fibrillation; however, this is yet to be proven in large-scale randomized controlled trials. This paper reviews the emerging role of rhythm control therapy for atrial fibrillation to prevent stroke. Korean Stroke Society 2016-05 2016-05-31 /pmc/articles/PMC4901955/ /pubmed/27283277 http://dx.doi.org/10.5853/jos.2016.00234 Text en Copyright © 2016 Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Review
Kim, Young-Hoon
Roh, Seung-Young
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title_full The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title_fullStr The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title_full_unstemmed The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title_short The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
title_sort mechanism of and preventive therapy for stroke in patients with atrial fibrillation
topic Special Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901955/
https://www.ncbi.nlm.nih.gov/pubmed/27283277
http://dx.doi.org/10.5853/jos.2016.00234
work_keys_str_mv AT kimyounghoon themechanismofandpreventivetherapyforstrokeinpatientswithatrialfibrillation
AT rohseungyoung themechanismofandpreventivetherapyforstrokeinpatientswithatrialfibrillation
AT kimyounghoon mechanismofandpreventivetherapyforstrokeinpatientswithatrialfibrillation
AT rohseungyoung mechanismofandpreventivetherapyforstrokeinpatientswithatrialfibrillation